Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation t…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Cogent Biosciences, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Cogent Biosciences, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Cogent Biosciences, Inc..